Long-term outcome of ultrasound-guided percutaneous ethanol ablation of selected "recurrent" neck nodal metastases in 25 patients with TNM stages III or IVA papillary thyroid carcinoma previously treated by surgery and 131I therapy

Surgery (United States)

Volumn 154, Issue 6, 2013, Pages 1448-1455

  Hay, Ian D ^a   Lee, Robert A ^a   Davidge Pitts, Caroline ^a   Reading, Carl C ^a   Charboneau, J William ^a  

^a Department of Health Sciences Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; IODINE 131; THYROGLOBULIN;

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPARATIVE STUDY; ECHOGRAPH; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; LONG TERM CARE; MALE; NECK DISSECTION; NECK METASTASIS; NECK NODAL METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT CANCER; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TUMOR ABLATION; TUMOR VOLUME; ULTRASOUND GUIDED PERCUTANEOUS ETHANOL ABLATION; ULTRASOUND TRANSDUCER;

ADULT; AGED; CARCINOMA; CARCINOMA, PAPILLARY; ETHANOL; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NEOPLASM STAGING; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84888016589     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.07.007     Document Type: Article

References (25)

1. I.D. Hay Papillary thyroid carcinoma I.D. Hay, J.A.H. Wass, Clinical endocrine oncology 2nd ed. 2008 Blackwell Publishing Oxford 130 142
2. M.J. Schlumberger, S. Filetti, and I.D. Hay Non-toxic diffuse and nodular goiter and thyroid neoplasia S. Melmed, K.S. Polonsky, P.R. Larsen, H.M. Kronenberg, Williams textbook of endocrinology 12th ed. 2011 Elsevier Saunders Philadelphia 440 478
3. S.K.G. Grebe, and I.D. Hay Thyroid cancer nodal metastases: biological significance and therapeutic considerations Surg Clin North Am 5 1996 43 63
4. I.D. Hay Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000 Trans Am Clin Climatol Assoc 113 2002 241 260
5. C.S. Grant, J.M. Stulak, G.B. Thompson, M.L. Richards, C.C. Reading, and I.D. Hay Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006 World J Surg 34 2010 1239 1246
6. I.D. Hay, E.J. Bergstralh, C.S. Grant, B. McIver, G.B. Thompson, and J.A. van Heerden Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989 Surgery 126 1999 1173 1182
7. M. Torlantano, M. Attard, U. Crocetti, S. Tumino, R. Bruno, and G. Costante Follow-up of low risk patients with papillary thyroid cancer; role of neck ultrasonography in detecting lymph node metastases J Clin Endocrinol Metab 89 2004 3402 3407
8. J.A. Sipos Advances in ultrasound for the diagnosis and management of thyroid cancer Thyroid 19 2009 1363 1372
9. A.M. Chindris, N.N. Diehl, J.E. Crook, V. Fatourechi, and R.C. Smallridge Undetectable sensitive serum thyroglobulin (<0.1ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up J Clin Endocrinol Metab 97 2012 2714 2723
10. D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, and S.J. Mandel Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer Thyroid 19 2009 1167 1214
11. G. Rondeau, and R.M. Tuttle Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United States Semin Nucl Med 41 2011 89 95
12. K.D. Burman Treatment of recurrent or persistent cervical node metastases in differentiated thyroid cancer: deceptively simple options J Clin Endocrinol Metab 97 2012 2623 2625
13. I.D. Hay, I.R. McDougall, and J.C. Sisson Perspective: the case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma J Nucl Med 49 2008 1395 1397
14. O. Al-Saif, W.B. Farrar, M. Bloomston, K. Porter, M.D. Ringel, and R.T. Kloos Long-term efficacy of lymph node re-operation for persistent papillary thyroid cancer J Clin Endocrinol Metab 95 2010 2187 2194
15. J.H. Yim, W.B. Kim, E.Y. Kim, W.G. Kim, T.Y. Kim, and J.S. Ryu The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation J Clin Endocrinol Metab 96 2011 2049 2056
16. J.H. Yim, W.B. Kim, E.Y. Kim, W.G. Kim, T.Y. Kim, and J.S. Ryu Adjuvant radioactive therapy after reoperation for locoregionally recurrent papillary thyroid cancer in patients who initially underwent total thyroidectomy and high-dose remnant ablation J Clin Endocrinol Metab 96 2011 3695 3700
17. J.E. Shin, J.H. Baek, and J.H. Lee Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers; current status and challenges Curr Opin Oncol 25 2013 14 19
18. J.M. Monchik, G. Donatini, J. Iannuccilli, and D.E. Dupuy Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma Ann Surg 244 2006 296 304
19. B.D. Lewis, I.D. Hay, J.W. Charboneau, B. McIver, C.C. Reading, and J.R. Goellner Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma AJR 178 2002 699 704
20. C.Y. Lim, J.S. Yun, J. Lee, K.H. Nam, W.Y. Chung, and C.S. Park Percutaneous ethanol injection therapy for locally recurrent papillary thyroid carcinoma Thyroid 17 2007 347 350
21. B.M. Kim, M.J. Kim, E.K. Kim, S.I. Park, C.S. Park, and W.Y. Chung Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection Eur Radiol 18 2008 835 842
22. A. Heilo, E. Sigstad, K.H. Fagerlid, O.I. Haskjold, K.K. Groholt, and A. Berner Efficacy of ultrasound-guided percutaneous ethanol injection treatment in patients with a limited number of metastatic cervical lymph nodes from papillary thyroid carcinoma J Clin Endocrinol Metab 96 2011 2750 2755
23. I.D. Hay Ablative percutaneous ultrasound-guided ethanol injection for neck nodal metastases in papillary and sporadic medullary thyroid carcinoma G.W. Randolph, Surgery of the thyroid and parathyroid glands 2nd ed. 2012 Saunders Philadelphia 511 519
24. E. Papini, G. Bizzarri, A. Bianchini, D. Valle, I. Misischi, and R. Guglielmi Percutaneous ultrasound-guided laser ablation is effective for treating selected nodal metastases in papillary thyroid cancer J Clin Endocrinol Metab 98 2013 E92 E97
25. I.D. Hay, and J.W. Charboneau The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well differentiated thyroid carcinoma J Clin Endocrinol Metab 96 2011 2717 2720